hpv vaccine types 6 and 11 (low-risk types) and 16 and 18 (high-risk types) were detected in 3.4% of female participants; hpv-6 was detected in 1.3% (95% ci, 0.8%-2.3%), hpv-11 in 0.1% (95% ci, 0.03%-0.3%), hpv-16 in 1.5% (95% ci, 0.9%-2.6%), and hpv-18 in 0.8% (95% ci, 0.4%-1.5%) of female participants.